{"id":4271,"date":"2018-05-04T19:29:52","date_gmt":"2018-05-04T23:29:52","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4271"},"modified":"2018-05-04T19:29:52","modified_gmt":"2018-05-04T23:29:52","slug":"ipo-pipeline-update-week-ending-5-4-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-week-ending-5-4-18\/","title":{"rendered":"IPO Pipeline Update – Week Ending 5.4.18"},"content":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of May 4, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"Screen<\/a><\/p>\n

NEW FILINGS<\/strong><\/span><\/p>\n

NEW FILINGS<\/strong><\/span>
\nCompany: Scholar Rock Holding Corporation
\nSymbol: SRRK
\nDescription: They are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Jefferies, Cowen, BMO Capital
\nCo-Manager(s): Wedbush PacGrow
\nFiled: 4-27-18
\nListed Cash Raise: $75m<\/p>\n

Company: Kiniksa Pharmaceuticals, Ltd.
\nSymbol: KNSA
\nDescription: They are a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Goldman Sachs, J.P. Morgan
\nCo-Manager(s): JMP Securities, Wedbush PacGrow
\nFiled: 4-27-18
\nListed Cash Raise: $100m<\/p>\n

Company: GreenSky, Inc.
\nSymbol: GKSY
\nDescription: They are a leading technology company that powers commerce at the point of sale.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Goldman Sachs & Co., J.P. Morgan, Morgan Stanley, BofA Merrill Lynch, Citigroup, Credit Suisse, SunTrust Robinson Humphrey
\nCo-Manager(s): Raymond James, Sandler O’ Neill, Fifth Third Securities, Guggenheim Securities
\nFiled: 4-27-18
\nListed Cash Raise: $100m<\/p>\n

Company: Iterum Therapeutics plc
\nSymbol: ITRM
\nDescription: They are a pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Leerink Partners, RBC Capital Partners
\nCo-Manager(s): Guggenheim Securities, Needham & Co.
\nFiled: 5-1-18
\nListed Cash Raise: $92m<\/p>\n

Company: DERMADoctor, Inc.
\nSymbol: DDOC
\nDescription: They are an omni-channel, innovative, skincare company primarily focused on the creation of products that are designed to target common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris.
\nTrade Date: TBD
\nShares: 1.875 million
\nPrice Range: $7.00-$9.00
\nUnderwriter(s): ThinkEquity
\nFiled: 5-2-18
\nListed Cash Raise: $17.25m<\/p>\n

TERMS ADDED<\/strong><\/span><\/p>\n

Company: Evelo Biosciences, Inc.
\nSymbol: EVLO
\nDescription: Evelo Biosciences is discovering and developing potential therapies designed to act on the gut-body network.
\nTrade Date: 5\/9
\nShares: 5.3 million
\nPrice Range: $15.00-$17.00
\nUnderwriter(s): Morgan Stanley, Cowen, BMO Capital Markets
\nCo-Manager(s): JMP Securities
\nTerms Added: 4-30-18<\/p>\n

Company: HUYA, Inc.
\nSymbol: HUYA
\nDescription: They are the No.1 game live streaming platform in China.
\nTrade Date: 5\/11
\nShares: 15 million ADS
\nPrice Range: $10.00-$12.00
\nUnderwriter(s): Credit Suisse, Goldman Sachs (Asia), UBS Investment Bank
\nCo-Manager(s): Needham & Co.
\nTerms Added: 5-1-18<\/p>\n

Company: Abpro Corporation
\nSymbol: ABP
\nDescription: They are a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of patients with severe and life-threatening diseases.
\nTrade Date: 5\/11
\nShares: 4 million
\nPrice Range: $14.00-$16.00
\nUnderwriter(s): UBS Investment Bank, Wells Fargo Securities, Nomura, Oppenheimer & Co.
\nTerms Added: 5-2-18<\/p>\n","protected":false},"excerpt":{"rendered":"

IPO Boutique keeps apprised of the active pipeline. Currently there are 54 active IPOs in the pipeline as of May 4, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS NEW FILINGS[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4271","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4271"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4271\/revisions"}],"predecessor-version":[{"id":4273,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4271\/revisions\/4273"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}